Page 42 - Read Online

Piñeiro et al. J Cancer Metastasis Treat 2021;7:10 I http://dx.doi.org/10.20517/2394-4722.2020.115 Page 13 of 13

64. Cartoni C, Brunetti GA, D'Elia GM, et al. Cost analysis of a domiciliary program of supportive and palliative care for patients with
hematologic malignancies. Haematologica 2007;92:666-73.
65. Centro de Coordinación de Alertas y Emergencias Sanitarias. Documento técnico: Manejo do- miciliario del COVID-19 [Online]. Madrid,
España: Dirección General de Salud Pública, Calidad e Innovación, Ministerio de Sanidad; 2020 Available at: https://www.mscbs.gob.es/
profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Manejo_primaria.pdf [Last Accessed on 2 Feb 2021]
66. Wanden-Berghe C, Sanz-Valero J. La Hospitalización a Domicilio en la enfermedad del COVID-19. Hosp Domic 2020;4:5-7.
67. Tralongo P, Ferraù F, Borsellino N, et al. Cancer patient-centered home care: a new model for health care in oncology. Ther Clin Risk
Manag 2011;7:387-92.
68. Depledge J. Chemotherapy in the community for adult patients with cancer. Br J Community Nurs 2012;17:214-20.
69. Murthy V, Wilson J, Suhr J, et al. Moving cancer care closer to home: a single-centre experience of home chemotherapy administration
for patients with myelodysplastic syndrome. ESMO Open 2019;4:e000434.
70. Finley C, Prashad A, Camuso N, et al. Guidance for management of cancer surgery during the COVID-19 pandemic. Can J Surg
2020;63:S2-S4.
71. Kumar S, Chmura S, Robinson C, et al. Alternative multidisciplinary management options for locally advanced NSCLC during the
Coronavirus Disease 2019 global pandemic. J Thorac Oncol 2020;15:1137-46.
72. Muralidhar V, Dee EC, D'Amico AV. Sequencing treatments for cancer during the COVID-19 pandemic. Am J Clin Oncol 2020;43:457-8.
73. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19.
Ann Intern Med 2020;172:756-8.
74. Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020;21:e180.
75. Salinas P, Travieso-González A, Vergara-Uzcategui CE, Macaya F, Núñez-Gily IJ, Fernández-Ortiz A. Temporal relation between
invasively managed acute coronary syndromes and confinement during the current COVID-19 pandemic. REC Interv Cardiol 2020;2:307-9
76. British Columbia Cancer Agency. COVID-19 and cancer treatments-Information for patients. March 23, 2020. Available from: www.
bccancer. bc.ca/about/news-stories/news/2020/covid-19-and-cancer-treatments. [Last Accessed on 2 Feb 2021]
77. Cancer Council of Australia. Information and support regarding cancer and COVID-19. Available from: https://www.cancer.org.au/
support-and-services/cancer-and-covid-19. [Last Accessed on 2 Feb 2021]
78. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of systemic anticancer treatments. March 20,
2020. Available from: https://www.nice.org.uk/guidance/ng161 [Last Accessed on 2 Feb 2021]
79. European Society of Medical Oncology. COVID-19 and cancer. Available from: www.esmo.org/newsroom/covid-19-and-cancer?hit=ehp.
[Last Accessed on 2 Feb 2021]
80. Royal College of Radiologists. Repository of advisory documents for cancer treatment during the coronavirus (COVID-19) pandemic.
Available from: https://www.rcr.ac.uk/college/coronavirus-covid-19-what-rcr-doing/clinical-information/coronavirus-covid-19-cancer
[Last Accessed on 2 Feb 2021]
81. Mannelli C. Whose life to save? Scarce resources allocation in the COVID-19 outbreak. J Med Ethics 2020;46:364-6.
82. Ueda M, Martins R, Hendrie PC, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a
common goal. J Natl Compr Canc Netw 2020;18:1-4.
83. American College of Surgeons. Ethical framework for the allocation of resources in the event of shortages. Available from: www.facs.org/
covid-19/ ethics. [Last Accessed on 2 Feb 2021]
84. Sterpetti AV. Lessons learned during the COVID-19 virus pandemic. J Am Coll Surg 2020;230:1092-3.
85. Doherty GJ, Goksu M, de Paula BHR. Rethinking cancer clinical trials for COVID-19 and beyond. Nat Cancer 2020;29:1-5.
86. Shuman AG, Pentz RD. Cancer research ethics and COVID-19. Oncologist 2020;25:458-9.
87. Zhang WR, Wang K, Yin L, et al. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in
China. Psychother Psychosom 2020;89:242-50.
88. Demartini K, Konzen VM, Siqueira MO, et al. Care for frontline health care workers in times of COVID-19. Rev Soc Bras Med Trop
2020;53:e20200358.
89. Sykes C, Borthwick C, Baker E. Mental health and wellbeing in the medical profession. The British Medical Association 2019. Available
from: https://www.bma.org.uk/media/1362/bma-mental-health-and-wellbeing-medical-profession-full-report-oct-2019.pdf. [Last
Accessed on 2 Feb 2021]
90. Macía-Rodríguez C, Martín Iglesias D, Moreno Diaz J, et al. Síndrome de burnout en especialistas en medicina interna y factores
asocaidos a su desarrollo. Revista Clínica Española 2020;6:331-8.
91. Chen Q, Liang M, Li Y, et al. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry
2020;7:e15-6.
92. Greenbaum Z. Psychologist leads innovative approach to tackle psychological toll of COVID-19. Am Psychol Assoc Available from:
https://www.apa.org/news/apa/2020/03/psychologist-covid-19. [Last Accessed on 2 Feb 2021]
93. Vlessides M. COVID-19: Mental health pros come to the aid of frontline comrades. Medscape 2020. Available from https://www.
medscape.com/viewarticle/928004?nlid=134830_2052&src=WNL_mdplsnews_200403_mscpedit_psyc&uac=216237CR&spon=12&im
pID=2334311&faf=1 [Last Accessed on 2 Feb 2021]
94. Forman R, Atun R, McKee M, Mossialos E. 12 Lessons learned from the management of the coronavirus pandemic. Health Policy
2020;124:577-80.
95. Coccia M. Problem-driven innovations in drug discovery: Co-evolution of the patterns of radical innovation with the evolution of
problems. Health Policy Technol 2016;5:143-55.